First line therapy with Lenalidomide and Dexamethasone in transplant-ineligible patients with multiple myeloma: Final results of the observational study FIRST-NIS.

3. August 2021

Nückel H., Behlendorf T., Schulz H., Schulze M., Söling U., Bürkle D., Koenigsmann M., Medinger T., Dechow T., Schardt C., Vannier C., Niemeier B., Schmidt B., Rauh J., Potthoff K.

Download